AI Medical Technology

Analyzes high-resolution dermatological images to identify melanoma with sensitivity comparable to board-certified dermatologists. Uses deep learning models trained on large datasets of clinically-validated skin lesion images to classify suspicious pigmented lesions.

Identifies and classifies non-melanoma skin cancers including basal cell carcinoma and squamous cell carcinoma from clinical images. Provides differential diagnosis to help clinicians triage lesions requiring immediate intervention versus monitoring.

Generates standardized triage recommendations that help clinicians decide whether a lesion requires specialist referral, biopsy, monitoring, or reassurance. Integrates risk assessment with clinical workflow to reduce unnecessary dermatology referrals.

Automatically generates standardized clinical documentation of AI analysis results and integrates findings directly into existing electronic health record systems. Creates structured records suitable for pathology correlation and clinical follow-up.

Provides performance metrics and quality assurance data comparing AI diagnostic accuracy against board-certified dermatologist performance and pathology-confirmed outcomes. Enables clinics to validate system performance in their specific patient population.

Establishes standardized protocols for skin lesion screening across clinical settings, including image capture guidelines, documentation templates, and decision pathways. Reduces variability in how lesions are evaluated and documented.

Enables non-dermatologists in primary care and underserved settings to confidently screen and identify suspicious skin lesions, effectively extending diagnostic capability beyond traditional dermatology access. Reduces diagnostic delays for patients in areas with limited specialist availability.